Selected Publications

2026

• Systemic treatment of cutaneous leishmaniasis: A systematic review and meta-analysis. 

Egg M, Wienand D, Harpain L, Brunner-Kovarik ML, Walochnik J, Wiesmueller M, Hampel A, Spath T, Trnka L, Simon J, Handisurya A. J Eur Acad Dermatol Venereol. 2026 Sep 8. doi: 10.1111/jdv.70711. 

• Esophageal papillomas and human papillomavirus infection: A case series, scoping review and analysis. 

Egg M, Dolak W, Mozayani B, Simbrunner B, Janik S, Wiesmüller M, Huber B, Tribl B, Madl U, Trauner M, Handisurya A, Kazemi-Shirazi L. J Clin Virol. 2026 Jun;184:105943. doi: 10.1016/j.jcv.2026.105943. 

• The Controversial Link Between Human Papillomavirus Infection and Esophageal Health: An Exploratory Translational Study. 

Egg M, Wiesmüller M, Aschenbrenner B, Kazemi-Shirazi L, Dolak W, Mozayani B, Kirnbauer R, Trauner M, Huber B, Handisurya A. Pathogens. 2026 Jan 15;15(1):96. doi: 10.3390/pathogens15010096.

2025

• Occupation: a predisposing factor for SARS-CoV-2 infection among hospital employees? A single-centre retrospective cohort study conducted in Austria. 

Egg M, Spath T, Brunner-Ziegler S, Hana CA, Radner-Lechner H, Urban N, Czerny S, Thalhammer F, Strassl R, Jilma B, Parschalk B, Schnetzinger M, Handisurya A. BMJ Public Health. 2025 Nov 19;3(2):e002300. doi: 10.1136/bmjph-2024-002300. 

• Off-label treatment with miltefosine for complex, pediatric Old World cutaneous leishmaniasis. 

Buchelt M, Valero T, Kinaciyan T, Walochnik J, Egg M, Szelenyi A, Langer S, Handisurya A. JAAD Case Rep. 2025 Jul 30;64:26-29. doi: 10.1016/j.jdcr.2025.05.054.

2024

• BRAF Inhibition and UVB Light Synergistically Promote Mus musculus Papillomavirus 1-Induced Skin Tumorigenesis. 

Dorfer S, Ressler JM, Riebenbauer K, Kancz S, Purkhauser K, Bachmayr V, Cataisson C, Kirnbauer R, Petzelbauer P, Wiesmueller M, Egg M, Hoeller C, Handisurya A. Cancers (Basel). 2024 Sep 11;16(18):3133. doi: 10.3390/cancers16183133. 

• Disseminated bullous eruptions: bed bugs! 

Egg M, Lisy M, Bauer W, Hampel A, Valencak J, Karlhofer F, Walochnik J, Handisurya A. J Dtsch Dermatol Ges. 2024 Jul;22(7):999-1002. doi: 10.1111/ddg.15392. 

• Comparison of topical permethrin 5% vs. benzyl benzoate 25% treatment in scabies: a double-blinded randomized controlled trial. 

Meyersburg D, Hoellwerth M, Brandlmaier M, Handisurya A, Kaiser A, Prodinger C, Bauer JW. Br J Dermatol. 2024 Mar 15;190(4):486-491. doi: 10.1093/bjd/ljad501. 

• On the impact of surveillance test strategies: a cost-benefit modelling analysis based upon real-world data from SARS-CoV-2. 

Spath T, Kundi M, Strassl R, Kornek G, Wetzlinger H, Thalhammer F, Handisurya A. Public Health. 2024 Mar;228:1-7. doi: 10.1016/j.puhe.2023.12.027.

• The changing epidemiology of human leishmaniasis in the non-endemic country of Austria between 2000 to 2021, including a congenital case. 

Riebenbauer K, Czerny S, Egg M, Urban N, Kinaciyan T, Hampel A, Fidelsberger L, Karlhofer F, Porkert S, Walochnik J, Handisurya A. PLoS Negl Trop Dis. 2024 Jan 10;18(1):e0011875. doi: 10.1371/journal.pntd.0011875. 

2023

• Riebenbauer K, Purkhauser K, Walochnik J, Urban N, Weber PB, Stamm T, Handisurya A. Detection of a knockdown mutation in the voltage-sensitive sodium channel associated with permethrin tolerance in Sarcoptes scabiei var. hominis mites. J Eur Acad Dermatol Venereol. 2023 Jun 25. doi: 10.1111/jdv.19288.
• Lisy M, Urban N, Brunner-Ziegler S, Weber B, Bauer WM, Dassler E, Koppensteiner R, Handisurya A.Temporal association between COVID-19 vaccination and Raynaud's phenomenon: A case series. Hum Vaccin Immunother. 2023 Dec 31;19(1):2199653. doi: 10.1080/21645515.2023.2199653.
• Brunner-Ziegler S, Bäuerle M, Brühl P, Kornek G, Parschalk B, Savic R, Schnetzinger M, Spath T, Straßl RP, Handisurya A*, Thalhammer F*.* equal contribution. Long COVID symptoms in hospital employees after post-vaccination SARS-CoV-2 infection in Austria: A study on self-reported incidence and associated factors. J Infect Public Health. 2023 Apr;16(4):596-602. doi: 10.1016/j.jiph.2023.02.017.
• Meyersburg D, Welponer T, Kaiser A, Selhofer S, Tatarski R, Handisurya A, Bauer JW. "Comparison of topical benzyl benzoate vs. oral ivermectin in treating scabies - A randomized study.". J Eur Acad Dermatol Venereol. 2023 Jan;37(1):160-165. doi: 10.1111/jdv.18573.

2022

• Urban N, Valencak J, Bauer WM, Thalhammer F, Handisurya A. Diary of human monkeypox: Illustrations of the clinical course. J Eur Acad Dermatol Venereol. 2022 Dec 3. doi: 10.1111/jdv.18802.
• Spath T, Brunner-Ziegler S, Stamm T, Thalhammer F, Kundi M, Purkhauser K, Handisurya A.Modeling the protective effect of previous compulsory smallpox vaccination against human monkeypox infection: from hypothesis to a worst-case scenario. Int J Infect Dis. 2022 Nov;124:107-112. doi: 10.1016/j.ijid.2022.09.022.
• Kartnig F, Mrak D, Simader E, Tobudic S, Radner H, Mandl P, Göschl L, Hommer N, Mayer M, Hofer P, Hummel T, Deimel T, Geßl I, Puchner A, Kerschbaumer A, Thalhammer R, Handisurya A, Kain R, Winkler S, Smolen JS, Stiasny K, Perkmann T, Haslacher H, Aberle JH, Aletaha D, Heinz LX, Sieghart D, Bonelli M. Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controls. Ann Rheum Dis. 2022 Sep 15:annrheumdis-2022-222682. doi: 10.1136/ard-2022-222682.
• Riebenbauer K, Weber PB, Haitel A, Walochnik J, Valencak J, Meyersburg D, Kinaciyan T, Handisurya A. Comparison of Permethrin-Based Treatment Strategies against Scabies in Infants and Young Children. J Pediatr. 2022 Jun;245:184-189. doi: 10.1016/j.jpeds.2022.02.016.

2021
 

• Urban N, Weber B, Deinsberger J, Gschwandtner M, Bauer W, Handisurya A. Raynaud's Phenomenon after COVID-19 Vaccination: Causative Association, Temporal Connection, or Mere Bystander? Case Rep Dermatol. 2021 Sep 15;13(3):450-456. doi: 10.1159/000519
• Riebenbauer K, Weber PB, Walochnik J, Karlhofer F, Winkler S, Dorfer S, Auer H, Valencak J, Laimer M, Handisurya A. Human dirofilariosis in Austria: the past, the present, the future.
  Parasit Vectors. 2021 Apr 29;14(1):227. doi: 10.1186/s13071-021-04696-4.
• Dorfer S, Strasser K, Schröckenfuchs G, Bonelli M, Bauer W, Kittler H, Cataisson C, Fischer MB, Lichtenberger BM, Handisurya A. Mus musculus papillomavirus 1 is a key driver of skin cancer development upon immunosuppression. Am J Transplant. 2021 Feb;21(2):525-539. doi: 10.1111/ajt.16358.
• Dorfer S, Strasser K, Reipert S, Fischer MB, Shafti-Keramat S, Bonelli M, Schröckenfuchs G, Bauer W, Kancz S, Müller L, Handisurya A. Deficiency of Cathelicidin-related Antimicrobial Peptide Promotes Skin Papillomatosis in Mus musculus Papillomavirus 1-infected Mice. Acta Derm Venereol. 2021 Jan 5;101(1):adv00367. doi: 10.2340/00015555-3733.

Link to Pubmed with all papers:

https://pubmed.ncbi.nlm.nih.gov/?term=allesandra+handisurya